ARIAD to Present at the Jefferies 2013 Global Healthcare Conference Jefferies Global Healthcare Conference 2013 Business Wire CAMBRIDGE, Mass. -- May 30, 2013 ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the Jefferies 2013 Global Healthcare Conference being held in New York City. Timothy P. Clackson, Ph.D., president of research and development and chief scientific officer, will provide an overview of the Company’s business on Wednesday, June 5, 2013 at 10:00 a.m. (ET). The ARIAD presentation will be webcast live and can be accessed by visiting the investor relations section of the Company's website at http://www.ariad.com/investor. A replay of the presentation will also be available and archived on the site for three weeks. About ARIAD ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts and Lausanne, Switzerland, is an integrated global oncology company focused on transforming the lives of cancer patients with breakthrough medicines. ARIAD is working on new medicines to advance the treatment of various forms of chronic and acute leukemia, lung cancer and other difficult-to-treat cancers. ARIAD utilizes computational and structural approaches to design small-molecule drugs that overcome resistance to existing cancer medicines. For additional information, visit http://www.ariad.com or follow ARIAD on Twitter (@ARIADPharm). Contact: ARIAD Pharmaceuticals, Inc. For Investors Kendra Adams, 617-503-7028 Kendra.firstname.lastname@example.org or For Media Liza Heapes, 617-621-2315 Liza.email@example.com
ARIAD to Present at the Jefferies 2013 Global Healthcare Conference
Press spacebar to pause and continue. Press esc to stop.